NuCana plc (NCNA) shareholders
Close on Nov 16, 2026Market cap $3.58MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Hugh S. Griffith | 2,829,961,890 | 12.00% | 13D (active) | Jun 20, 2025 |
| Antoine Papiernik Joint filing with Sofinnova Capital VI FCPR (5.10%), Sofinnova Partners SAS (5.10%) and 5 more | 4,987,975 | 5.10% | 13D (active) amendment | Feb 14, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NCNA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| StoneX Group Inc. | 47,043 | 0.00% | $71.51K | New | 0.00% |
| Citadel Advisors LLC | 27,099 | 0.00% | $41.19K | +13,244 | 0.00% |
| Hrt Financial LP | 16,870 | 0.00% | $25.00K | New | 0.00% |
| Glass Jacobson Investment Advisors llc | 15,000 | 0.00% | $22.80K | – | 0.01% |
| Rhumbline Advisers | 4,698 | 0.00% | $7.14K | +976 | 0.00% |
| Citigroup Inc | 188 | 0.00% | $286 | New | 0.00% |
| Integrated Wealth Concepts LLC | 188 | 0.00% | $286 | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 5 | 0.00% | $8 | +3 | 0.00% |
| Morgan Stanley | 2 | 0.00% | $3 | – | 0.00% |
| Acadian Asset Management LLC | 2 | 0.00% | $0 | – | 0.00% |
| SBI Securities Co., Ltd. | 1 | 0.00% | $2 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 11 | 0M | 0.0% | 5 / 3 | 0 / 2 | 0M | 0M |
| Q1 2026 | 8 | 0M | 0.0% | 3 / 0 | 3 / 4 | 0M | 0M |
| Q4 2025 | 9 | 0M | 0.0% | 1 / 3 | 2 / 2 | 0M | 0M |
| Q3 2025 | 10 | 0M | 0.0% | 4 / 5 | 0 / 11 | 0M | 0M |
| Q2 2025 | 17 | 0M | 0.0% | 9 / 2 | 1 / 4 | 0M | 0M |
| Q1 2025 | 12 | 0M | 0.0% | 3 / 1 | 3 / 10 | 0M | 0M |
| Q4 2024 | 20 | 0M | 0.0% | 8 / 3 | 2 / 6 | 0M | 0M |
| Q3 2024 | 18 | 0M | 0.0% | 6 / 2 | 1 / 1 | 0M | 0M |
| Q2 2024 | 13 | 0M | 0.0% | 12 / 0 | 0 / 0 | 0M | 0M |
| Q1 2024 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
1 funds held NCNA in Q2 2026. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of NCNA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Blackstone Alternative Multi-Strategy Fund | -271 | -0.00% | -$412 | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Hugh Griffith | Chief Executive Officer, Director | 1,000,000 | 0.00% | Mar 18, 2026 |
| Jeffrey D. Bloss | Chief Medical Officer | 47,136 | 0.00% | Jun 23, 2026 |
| Theresa Margaret Ms Bruce | Chief Operating Officer | – | – | Apr 16, 2026 |
| David James Harrison | Head of Translational Medicine | – | – | Mar 24, 2026 |
| Ian Alexander Webster | See Remarks | – | – | Mar 18, 2026 |
| Elliott M. Levy | Director | 13 | 0.00% | Jun 24, 2026 |
| Martin C.B. Mellish | Director | 28 | 0.00% | Mar 20, 2026 |
| Cyrille Leperlier | Director | – | – | Mar 18, 2026 |
| Andrew Martin Kay | Director | – | – | Mar 18, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of NuCana's stock actually held short. Settlement fails (shares not delivered on time) peaked at 116,015 shares on Oct 1, 2026 over the last 90 days.
See a number that looks wrong?